Company Filing History:
Years Active: 2013-2017
Title: Michele Youd: Innovator in Anti-CXCR3 Antibodies
Introduction
Michele Youd is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of anti-CXCR3 antibodies. With a total of 3 patents to her name, Michele's work is paving the way for advancements in the treatment of various disorders.
Latest Patents
Michele Youd's latest patents focus on nucleic acids encoding anti-CXCR3 antibodies. These patents provide methods for using the antibodies to diagnose and treat CXCR3-associated disorders, such as diabetes mellitus type I (T1D), especially in cases of new-onset T1D. The disclosed embodiments include CXCR3 neutralizing antibodies, which hold promise for therapeutic applications.
Career Highlights
Michele is currently associated with Genzyme Corporation, where she continues to innovate and contribute to the field. Her expertise and dedication have positioned her as a key player in her area of research.
Collaborations
Michele has collaborated with notable coworkers, including Tracey Lodie and Jennifer Tedstone. These partnerships enhance the collaborative spirit of innovation within her team.
Conclusion
Michele Youd's work in developing anti-CXCR3 antibodies represents a significant advancement in the treatment of diabetes and related disorders. Her contributions to biotechnology are noteworthy and continue to impact the field positively.